The Ultimate Directory on Healthcare Webinars

Join Us for an Exclusive Webinar on Digital Health Transformation in Asia!We’re thrilled to invite you to our upcoming webinar, Digital Health Transformation in Asia, hosted in collaboration with @UNITAR.From AI-powered diagnostics to telemedicine and data-driven healthcare, digital innovations are reshaping the future of medical care. 🚀This webinar is tailored for professionals eager to stay ahead in the ever-evolving digital health landscape.📅 Date: 27 March📍 Mode: Online📢 What You’ll Gain from This Expert-Led Session:✔️ Insights on how digital health technologies are enhancing patient outcomes.✔️ The impact of AI, big data, and telehealth on modern healthcare.✔️ Best practices for successfully adopting and implementing digital solutions.Don’t miss out—secure your spot today!🔗 Register now: https://us02web.zoom.us/webinar/register/WN_58znH68wSbSmhXqpQF8zFQ#/registration

Join us to explore BounceBack®, the Canadian Mental Health Association’s free, evidence-based mental health program designed to reduce anxiety and depression symptoms by up to 50%. Grounded in Cognitive-Behavioural Therapy (CBT), this program offers BC residents aged 13+ practical strategies to manage stress, worry, unhelpful thinking, and more. Learn how self-selected workbooks and personalized support from a telephone coach over 4-6 sessions can help you take control of your mental well-being and navigate life’s challenges.Don’t miss this opportunity to learn how BounceBack® can make a difference in your life. Register today By the end of this webinar, participants will be able to: Understand the structure of BounceBack® program, including its focus on Cognitive-Behavioural Therapy (CBT) principles. Learn how the program for BC residents aged 13 and over can improve their mental wellbeing. Highlight evidence-based strategies participants can learn, such as managing stress, reducing worry, addressing unhelpful thinking, and facing mild to moderate anxiety and depression. Speakers: Stephanie Streicher, Quality Assurance and Training Coordinator, CMHA BC.Stephanie Streicher has been a part of the Canadian Mental Health Association’s BounceBack: Reclaim Your Health program for nine years, progressing from a community coach to her current position as Quality Assurance and Training Coordinator. In this role, she is responsible for supporting the operational aspects of program delivery across Canada, including BounceBack coach training and development. With over a decade of expertise in mental health service provision, spanning a range of healthcare environments and populations, Stephanie has developed a profound dedication to enhancing the accessibility, quality, and impact of mental health resources for Canadians.

Join us for an in-depth webinar focused on ANCA-associated vasculitis (AAV). This session will provide a comprehensive overview of the latest advancements in the diagnosis, monitoring, and management of AAV. The webinar will cover current treatment options and highlight best practices for managing patients throughout the disease course. Whether you're a clinician, researcher, or healthcare provider, don't miss the opportunity to deepen your knowledge and stay up-to-date on best practices for managing ANCA-associated vasculitis!Speakers: Lauren Floyd (University of Manchester) and Alvise Berti (S. Chiara Hospital and Centre for Medical Sciences (CISMed), University of Trento, Italy)

Immediate implant placement in the esthetic zone, represents one of the biggest challenges in dentistry. It implies a multidisciplinary approach involving prosthetic and periodontal aspects to obtain long term stability, esthetic and functional results. A clinical cases report arr presented, taking into consideration periodontal and prosthetic management of an implant in the anterior zone, starting from the diagnosis, treatment plan, periodontal surgical procedures, provisionalization, and its definitive prosthetic rehabilitation.Speaker: Prof. Angelo Cardarelli.

In this webinar, you will get to know:The latest treatment paradigms for first-line therapy in transplant-eligible patientsEvolving strategies for first-line therapy in transplant-ineligible patientsSecond-line treatment breakthroughs, including the resurgence of Belantamab MafodotinInnovative endpoints in the design of multiple myeloma clinical trialsKey opportunities and challenges in managing relapse and refractory diseaseSpeaker: Dr. Stavros Gkolfinopoulos - Associate Director, Global Safety Physician.

While synthetic biology has considerably advanced in the past decade, cost continues to be a major factor in commercial viability. Saccharomyces cerevisiae is a commonly used microbial host in synthetic biology. These cultures can be grown to very high densities with high expression levels of target molecules, making S. cerevisiae a preferred candidate for cost-effective natural product synthesis.In this webinar, the expert speakers demonstrate the seamless scale-up of a high-yield fermentation process from 250 mL to 5 L, enabled by extensive vessel characterization using cloud-connected bioreactors. The speakers will share insights into how utilizing S. cerevisiae provided an efficient and cost-effective scale-up method.They will also present case studies that illustrate the steps taken to reduce costs and mitigate risks during the scale-up process. The attendees will also gain a comprehensive understanding of how cloud-connected bioreactors can dramatically accelerate the scale-up process in biomanufacturing. The speakers will then delve into practical troubleshooting methods, designed to address and overcome common challenges encountered during scale-up.Moreover, the session will explore effective strategies for reducing costs and de-risking the scale-up process, equipping attendees with tools and knowledge needed to optimize production efficiency and ensure successful outcomes in their biomanufacturing projects.Register for this webinar to discover how cloud-connected bioreactors are revolutionizing the scale-up process for biomanufacturing.What You Will LearnAttendees will learn about:• How cloud-connected bioreactors can accelerate scale-up• Troubleshooting methods to overcome scale-up challenges• Strategies for reducing costs and de-risking scale-upWho Should Attend?This webinar will appeal to:• Small-Mid-Large Biotech/Pharma• Emerging biotechs and startups/Agricultural biotechnology firms• Food Technology and fermentation-based food companies• Biofuel and renewable chemical companies• Research institutions and academia• Bioprocess Engineers• Head of Process Development/Innovation• Upstream Process Development Scientists• Formulation Scientists• Product Development• Consultants/R&D/Scientists/FormulatorsSpeakers: Andrew Horwitz, PhD, Vice President Research and Development, Inscripta; Kris Tyner, Senior Director, Bioprocess Sciences, Culture Biosciences.

Pain is connected with emotional, cognitive, and behavioural disorders as well as functional issues. People living in long-term care facilities are often living with dementia or cognitive impairment, frailty and multiple comorbid conditions and can experience complex forms of pain. They are likely to experience issues with mental capacity and communication which can impact on their ability to articulate their pain and how this impacts upon them this has a significant impact on all aspects of their life and well-being. A person living with dementia may exhibit distressed behaviours as a result of experiencing pain and all too often this is considered indicative of a symptom of dementia as opposed to a manifestiation of unmanaged pain. Focusing on improving the identification, assessment and management of pain in residents living in long-term care is of the utmost importance.The webinar will cover: 1. Introduction to the Global Observatory of Long-Term care (Adelina Comas-Herrera, Care Policy and Evaluation Centre, LSE, UK). 2. Introduction to the GOLTC Pain in Care homes Interest Group • Dr. Zena Aldridge: Social Care Nurse Fellow NIHR, UK • Dr. Manuela Hoedl: Medical University of Graz • Prof. Sandra Zwakhalen: Maastricht University, Netherlands 3. Presentationsa) Developing consensus on core outcome sets of domains for acute, the transition from acute to chronic, recurrent/episodic, and chronic pain: results of the INTEGRATE-pain Delphi process. Giulia Bova (National Institute of Health, NINDS, UK) b) Discussion: Which COS can be integrated in Long-term care? What are the perquisites? What can be challenges.4. Q & A: Ideas/ further plans for improving pain management? 5. Discussion about the Interest Group next steps led by the steering group members.This webinar is free to attend with pre-registration.

Learn strategies to identify, prioritize, and address ergonomic hazards while fostering a culture of safety across all locations, with insights from Mary Lucot of Sanofi.We'll cover:• Make a big impact with simplified approaches to ergonomics• Techniques for sharing insights and safety protocols across locations to enhance workplace safety• Real-World examples and success storiesWho Should Watch?This webinar is perfect for safety and ergonomics professionals, operations managers, HR leaders, and anyone responsible for workplace health and safety managing multi-site operations.Whether you're new to ergonomics or looking to enhance an existing program, this session will provide the tools and knowledge you need to succeed.What You’ll Learn:• Simple ergonomic principles that enhance both safety and productivity.• Tips for standardizing ergonomic initiatives across locations to ensure consistent safety standards.• Metrics and tools to demonstrate ROI on ergonomic investments.• Real-world examples of successful ergonomic transformations.Guest: Mary Lucot, Global HSE Occupational Hygeine Expert.Reserve your spot to get access!

ISAM is pleased to announce the next Webinar presented by Clair Brooks, Applications Specialist at Copley Scientific, Nottingham, England, UK. She will explore the latest advancements in nasal drug delivery, focusing on in-vitro testing methods and innovative tools for improved nasal deposition.Key points:• Utilising the intranasal route for systemic and nose-to brain drug delivery • Compendial in vitro testing requirements of nasal drug products • Challenges and developments in nasal testing• Studying nasal deposition with the Alberta Idealised Nasal Inlet and the Kiel Nasal InletNasal drug delivery presents a promising avenue for therapeutic administration, offering a non-invasive route that bypasses the gastrointestinal tract and hepatic first-pass metabolism. This method has become increasingly attractive for systemic drug administration, particularly for drugs that are poorly absorbed orally, as it utilises the highly vascularised and large surface area of the nasal mucosa for rapid absorption. Additionally, the permeability of the nasal mucosa and its nerve pathways are being utilised to achieve targeted drug delivery to the brain, effectively overcoming the blood-brain barrier. Rigorous testing is vital to ensure the safety, efficacy and quality of these products, and compendial in-vitro testing methods play a key role in evaluating product performance and ensuring compliance with regulatory standards. However, challenges remain in replicating physiological conditions and addressing patient-to-patient variability. Ongoing research and technological advancements continue to drive progress in this area, including the development of realistic nasal models to improve in vitro-in vivo correlations and automated device actuation to standardise dose delivery when evaluating bioequivalence. This webinar explores the advancements in in-vitro nasal testing and presents recent studies using two novel tools to look at nasal deposition.

VJNeurology are excited to announce that we will be hosting a live webinar on Evolving Strategies in Stroke Management, as part of our series of live webinars focusing on key advances from 2024 in the diagnosis, treatment, and management of neurological disorders.6 Nov 2024 | 10:00-12:00 CST / 16:00-18:00 GMT / 17:00-19:00 CETChaired by Prof. Simona Sacco, President-Elect of the European Stroke Organisation, & University of L’Aquila, ItalyCo-moderated by Prof. Ashkan Shoamanesh, McMaster University, Canada & Prof. Rustam Al-Shahi Salman, University of Edinburgh, ScotlandAgenda:Session 1: Novel approaches using thrombolytics in ischemic strokeSession 2: Advances with thrombectomy for ischemic strokeSession 3: Latest in clinical decision-making in ischemic strokeSession 4: Recent progress in hemorrhagic stroke managementPlease note this webinar is open to healthcare professionals, allied health professionals & researchers only. Your application will be reviewed and confirmed once received.